
AML.L vs RNL.DE

In the past 12 months, RNL.DE returned -19% while AML.L lost 42%.
Valuation
Compare price multiples and valuation ratios
| Metric | AML.L | RNL.DE | Winner |
|---|---|---|---|
P/E Ratio Price to earnings ratio | -0.60 | 8.39 | AML.L |
Forward P/E Forward price to earnings ratio | 0.00 | 0.00 | Tie |
P/S Ratio Price to sales ratio | 0.22 | 0.13 | RNL.DE |
P/B Ratio Price to book ratio | 2.11 | 0.40 | RNL.DE |
P/FCF Ratio Price to free cash flow ratio | -1.49 | 4.00 | AML.L |
EV/EBITDA Enterprise value to EBITDA | 7.44 | 9.43 | AML.L |
PEG Ratio Price/earnings to growth ratio | 0.00 | 0.00 | Tie |
Profitability
Compare profit margins and returns on capital
| Metric | AML.L | RNL.DE | Winner |
|---|---|---|---|
Gross Margin Gross profit margin | 18.5% | 17.1% | AML.L |
Operating Margin Operating profit margin | -13.3% | 3.5% | RNL.DE |
Net Margin Net profit margin | -36.7% | 1.6% | RNL.DE |
ROE Return on equity | -166.6% | 4.6% | RNL.DE |
ROA Return on assets | -23.7% | 0.8% | RNL.DE |
ROIC Return on invested capital | -11.5% | 1.5% | RNL.DE |
Growth
Compare revenue and earnings growth rates
| Metric | AML.L | RNL.DE | Winner |
|---|---|---|---|
Revenue Growth (YoY) Year-over-year revenue growth | -20.6% | 0.0% | RNL.DE |
Revenue Growth (3Y) 3-year revenue CAGR | -3.1% | 0.0% | RNL.DE |
Revenue Growth (5Y) 5-year revenue CAGR | 15.5% | 0.0% | AML.L |
EPS Growth (YoY) Year-over-year EPS growth | -28.2% | 0.0% | RNL.DE |
EPS Growth (3Y) 3-year EPS CAGR | 0.0% | 0.0% | Tie |
EPS Growth (5Y) 5-year EPS CAGR | 0.0% | 0.0% | Tie |
Balance Sheet & Risk
Compare financial stability and debt levels
| Metric | AML.L | RNL.DE | Winner |
|---|---|---|---|
Debt/Equity Debt to equity ratio | 8.94 | 3.52 | RNL.DE |
Current Ratio Current assets to current liabilities | 0.93 | 1.03 | RNL.DE |
Quick Ratio Quick assets to current liabilities | 0.49 | 0.96 | RNL.DE |
Interest Coverage EBIT to interest expense | -1.43 | 11.25 | RNL.DE |
Beta Stock volatility vs market | 1.94 | 0.81 | RNL.DE |
7222.T
PSNY
LOT